Jon Rousseau, CEO, discusses the financial performance and strategies of the company in an earnings call. Key points include Medicaid mix reduction post-transaction, strong pharmacy performance, revenue breakdown, leverage ratio target, and capital deployment priorities.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing